Skip to main content

Table 3 Cancer Site by FN Status

From: Comparing cancer incidence, stage at diagnosis and outcomes of First Nations and all other Manitobans: a retrospective analysis

Cancer Site

FN (n = 1524)

AOM (n = 36,552)

p value

Bladder

13 (0.9%)

814 (2.2%)

0.0003

Breast

210 (13.8%)

5219 (14.3%)

0.5853

Cervix

43 (3.0%)

286 (0.8%)

< 0.0001

Chronic Lymphocytic Leukemia

7 (0.5%)

351 (1.8%)

0.0001

Colorectal

240 (15.7%)

5063 (13.9%)

0.0362

Kidney

136 (8.9%)

1177 (3.2%)

< 0.0001

Lung & Bronchus

205 (13.5%)

5306 (14.5%)

0.247

Melanoma

8 (0.5%)

988 (2.7%)

< 0.0001

Non-Hodgkin Lymphoma

65 (4.6%)

1609 (4.4%)

0.7985

Ovarian

32 (2.1%)

545 (1.5%)

0.0567

Pancreas

32 (2.1%)

914 (2.5%)

0.3247

Prostate

134 (8.8%)

4558 (12.5%)

< 0.0001

Stomach

29 (1.9%)

727 (2.0%)

0.8135

Thyroid

20 (1.3%)

667 (1.8%)

0.1409

Uterine

38 (2.5%)

1263 (3.5%)

0.0428

Other

355 (23.3%)

7051 (19.3%)

0.0714